# Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies

> **NCT07547826** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 164 (estimated)

## Conditions studied

- Hydrocephalus
- Ventriculoperitoneal Shunt Infection
- Surgical Site Infection (SSI)
- Cerebrospinal Fluid Shunt Infection
- Pediatric Hydrocephalus
- Hydrocephalus in Children
- Hydrocephalus in Infants
- Postoperative Complications
- Prosthesis-Related Infections
- Bacterial Infections and Mycoses

## Interventions

- **DRUG:** Topical Vancomycin Powder
- **PROCEDURE:** Standard Perioperative Care

## Key facts

- **NCT ID:** NCT07547826
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-05
- **Final completion:** 2027-12
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07547826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07547826, "Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07547826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*